Semaglutide peptide — the active compound in Ozempic, Wegovy, and Rybelsus — is a GLP-1 receptor agonist with a half-life extended through fatty acid conjugation enabling once-weekly dosing. This research guide covers the clinical dosing protocols, reconstitution for research use, and comparison with newer agents.
Why Semaglutide Has a Long Half-Life
Native GLP-1 has a plasma half-life of under 2 minutes due to DPP-4 degradation. Semaglutide overcomes this via two structural changes: a C18 fatty diacid chain attached to lysine-26 that binds albumin (slowing renal clearance), and substitution of alanine-8 with alpha-aminoisobutyric acid (blocking DPP-4). The result: a 7-day half-life enabling weekly subcutaneous administration.
Semaglutide Dosage Protocol (STEP-1 Escalation)
| Weeks | Dose (SC, once weekly) |
|---|---|
| 1–4 | 0.25 mg |
| 5–8 | 0.5 mg |
| 9–12 | 1.0 mg |
| 13–16 | 1.7 mg |
| 17+ | 2.4 mg (maintenance) |
Semaglutide vs Tirzepatide vs Retatrutide
Semaglutide (GLP-1 only) produced ~15% weight loss in STEP-1. Tirzepatide (GLP-1 + GIP) improved this to ~22.5%. Retatrutide (GLP-1 + GIP + glucagon) pushed further to ~24.2%. Each additional receptor mechanism provides incremental metabolic benefit, though also adds complexity to side effect management.
Free Tool
Peptide Reconstitution Calculator
Convert vial strength, water volume, and desired dose into precise syringe units. Works for BPC-157, TB-500, GHK-Cu, and all research peptides.
Try the Calculator →Research Notes
Semaglutide remains valuable for research where the established safety database is important, or where cardiovascular endpoint data (SELECT trial: 20% MACE reduction) is the primary variable of interest. For maximum weight reduction research, newer agents have surpassed it. Prax Peptides carries research-grade semaglutide with batch-specific third-party COAs.
Prax Peptides supplies research-grade compounds with 99%+ purity, verified by independent third-party analysis.
⚠️ Research Use Only: All compounds referenced on this site are intended strictly for laboratory research purposes. They are not approved for human use or consumption by the FDA or any regulatory authority. This content is for informational purposes only and does not constitute medical advice.